Skip to main content
OpenTrials

Clinical trial condition

Endometrial Adenocarcinoma

Explore clinical trials studying Endometrial Adenocarcinoma. Study availability and eligibility vary by location and protocol.

47 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Adenocarcinoma trial results

Completed

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT01210222

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +21 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • Memorial University Medical Center Savannah, Georgia, United States
View all 33 locations
View Trial Details
Completed

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00820898

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +1 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 20 locations
View Trial Details
Completed

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00888173

Conditions
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, +6 more
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Saint Vincent Hospital and Health Care Center Indianapolis, Indiana, United States
View all 35 locations
View Trial Details
Completed

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT01225887

Conditions
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, +6 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • Memorial University Medical Center Savannah, Georgia, United States
View all 59 locations
View Trial Details

Related conditions